Dr Ivana Damjanovic
Dr. Ivana Damjanovic is a highly accomplished medical researcher who has made significant contributions to our understanding of thyroid disorders and cancer. Her pioneering work has improved patient care and outcomes, and her commitment to education and mentorship has inspired a new generation of researchers and clinicians. As a leading expert in her field, Dr. Damjanovic continues to push the boundaries of medical research, driving innovation and excellence in the field of endocrinology.
She has written extensively on landmark legal shifts within Europe, such as the implications of the Achmea judgment, which declared intra-EU investor-state arbitration clauses incompatible with EU law. Her co-authored study published in the Columbia Journal of European Law , titled "Intra-EU Investment Dispute Settlement in Light of Vattenfall and Achmea: A Matter of Priority," remains a prominent reference for understanding how EU constitutional order takes precedence over international investment pacts. 3. Critical Minerals and Green Transition
Another notes: “She is expensive and she is busy, but she spends 90 minutes with you during the first visit. In a world of 7-minute appointments, that is revolutionary.” dr ivana damjanovic
at the Australian National University (ANU) Centre for European Studies. ⚖️ Areas of Expertise
Dr. Ivana Damjanovic: Bridging the Divide Between Diplomacy, Public Law, and Global Trade Reform As a leading expert in her field, Dr
Dr. Damjanović emphasizes that for safeguarding population health. She advocates for transparent communication, community engagement, and sustained investment in public health infrastructure—not just during crises, but as a continuous priority.
A central pillar of Damjanovic’s scholarship is her investigation into the "aspirations versus reality" of EU investment law reform. Her 2023 monograph, The European Union and International Investment Law Reform: Between Aspirations and Reality , published by Cambridge University Press, serves as a definitive analysis of this field. In it, she explores how the EU, having gained exclusive competence over foreign direct investment following the Treaty of Lisbon in 2009, has attempted to reshape the global investment regime. She critically evaluates the EU’s vision of the rule of law and its efforts to legitimize investor-state dispute settlement (ISDS) mechanisms, which have faced significant public and political backlash. Damjanovic argues that while the EU promotes multilateral solutions, it must navigate internal constitutional limitations and external complexities that often result in a "fragmentary" contribution to the international rule of law. Ivana DAMJANOVIC - University of Canberra Research Portal Her co-authored study published in the Columbia Journal
Consultant for various international legal and trade projects. Accredited Mediator in Australia. Key Publications and Research Leadership
Dr. Damjanovic responds to these critiques with grace, noting that “Functional medicine is not alternative medicine; it is root cause medicine. Just because a nutrition study wasn’t funded by a pharmaceutical company doesn’t make it invalid.”
Dr. Ivana Damjanovic: Bridging International Diplomacy and the Future of Global Investment Law
